Indications
Maintenance treatment in symptomatic adult patients with chronic obstructive pulmonary disease (COPD).
Composition
- Active substance
- ensifentrine
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Ohtuvayre
- Active substance
- ensifentrine
- ATC code
- R03BX
- Group
- Respiratory system
- Therapeutic area
- Pulmonary Disease, Chronic Obstructive
- Marketing authorisation holder
- Verona Pharma Ireland Limited
- Status
- Application withdrawn
- EMA product number
- EMEA/H/C/006742